RBC Europe’s Genetic Technologies Ltd. GENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4
| Closed | -$62 | – | 1207 |
|
|
2021
Q3 | $62 | Hold |
4
| – | – | ﹤0.01% | 1224 |
|
|
2021
Q2 | $85 | Hold |
4
| – | – | ﹤0.01% | 1213 |
|
|
2021
Q1 | $83 | Hold |
4
| – | – | ﹤0.01% | 1165 |
|
|
2020
Q4 | $72 | Hold |
4
| – | – | ﹤0.01% | 1137 |
|
|
2020
Q3 | $69 | Hold |
4
| – | – | ﹤0.01% | 1084 |
|
|
2020
Q2 | $46 | Hold |
4
| – | – | ﹤0.01% | 1052 |
|
|
2020
Q1 | $39 | Hold |
4
| – | – | ﹤0.01% | 1030 |
|
|
2019
Q4 | $40 | Hold |
4
| – | – | ﹤0.01% | 1040 |
|
|
2019
Q3 | $38 | Hold |
4
| – | – | ﹤0.01% | 1044 |
|
|
2019
Q2 | $47 | Hold |
4
| – | – | ﹤0.01% | 1055 |
|
|
2019
Q1 | $71 | Hold |
4
| – | – | ﹤0.01% | 1065 |
|
|
2018
Q4 | $44 | Hold |
4
| – | – | ﹤0.01% | 1080 |
|
|
2018
Q3 | $87 | Hold |
4
| – | – | ﹤0.01% | 1113 |
|
|
2018
Q2 | $79 | Hold |
4
| – | – | ﹤0.01% | 1127 |
|
|
2018
Q1 | $83 | Hold |
4
| – | – | ﹤0.01% | 1109 |
|
|
2017
Q4 | $93 | Hold |
4
| – | – | ﹤0.01% | 1120 |
|
|
2017
Q3 | $68 | Buy |
+4
| New | +$68 | ﹤0.01% | 1126 |
|